{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:59:05Z","timestamp":1793908745207,"version":"4.8.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":4723,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1046\/j.1523-1755.2003.00712.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T09:52:16Z","timestamp":1047462736000},"page":"225-232","source":"Crossref","is-referenced-by-count":1365,"title":["Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)"],"prefix":"10.1016","volume":"63","author":[{"given":"Amanda I.","family":"Adler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue E.","family":"Manley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy W.","family":"Bilous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole A.","family":"Cull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rury R.","family":"Holman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"UKPDS Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0010","series-title":"Diabetic Nephropathy","article-title":"The history of diabetic nephropathy","author":"Tattersal","year":"2000"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0015","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/jama.1997.03550230045035","article-title":"Risk of end-stage renal disease in diabetes mellitus: A prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial","volume":"278","author":"Brancati","year":"1997","journal-title":"JAMA"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0020","series-title":"The UK Renal Registry","article-title":"The Second Annual Report","author":"Ansell","year":"1999"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0025","first-page":"1557","article-title":"End-stage renal disease in Canada: Prevalence projections to 2005","volume":"160","author":"Schaubel","year":"1999","journal-title":"Can Med Assoc J"},{"issue":"Suppl","key":"10.1046\/j.1523-1755.2003.00712.x_bb0030","first-page":"S1","article-title":"Excerpts from the USRDS Annual Data Report","volume":"36","author":"US Renal Data System","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0035","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJM199611283352212","article-title":"Initiation and progression of diabetic nephropathy","volume":"335","author":"Parving","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0040","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/bmj.314.7083.783","article-title":"Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: Prospective, observational study","volume":"314","author":"Gall","year":"1997","journal-title":"BMJ"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0045","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.2337\/diacare.21.11.1932","article-title":"Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM","volume":"21","author":"Forsblom","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0050","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archinte.158.9.998","article-title":"Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia","volume":"158","author":"Ravid","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2337\/diab.37.4.405","article-title":"Epidemiology of persistent proteinuria in type II diabetes mellitus; Population-based study in Rochester, Minnesota","volume":"37","author":"Ballard","year":"1988","journal-title":"Diabetes"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0060","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s001250051023","article-title":"Plasma lipoproteins and the incidence of abnormal excretion of albumin in diabetic American Indians: The Strong Heart Study","volume":"41","author":"Fagot-Campagna","year":"1998","journal-title":"Diabetologia"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0065","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2337\/diacare.16.1.300","article-title":"A follow-up study of diabetic Oklahoma Indians: Mortality and causes of death","volume":"16","author":"Lee","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0070","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2337\/diacare.16.1.335","article-title":"Diabetic kidney disease in Pima Indians","volume":"16","author":"Nelson","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0075","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1056\/NEJM199611283352203","article-title":"Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus","volume":"22","author":"Nelson","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-8227(00)00153-4","article-title":"Evaluation of a simple, random urine test for prospective analysis of proteinuria in Type 2 diabetes: A six year follow-up study","volume":"49","author":"Viswanathan","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0085","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2337\/diabetes.49.3.476","article-title":"Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate","volume":"49","author":"Nosadini","year":"2000","journal-title":"Diabetes"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0090","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UKPDS Group","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0095","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","author":"UKPDS Group","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0100","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38)","volume":"317","author":"UKPDS Group","year":"1998","journal-title":"BMJ"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0105","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/bmj.317.7160.713","article-title":"Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39)","volume":"317","author":"UKPDS Group","year":"1998","journal-title":"BMJ"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0110","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1464-5491.1994.tb02032.x","article-title":"UK Prospective Diabetes Study XI: Biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects","volume":"11","author":"UKPDS Group","year":"1994","journal-title":"Diabetic Med"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0115","first-page":"835","article-title":"UK Prospective Diabetes Study IX: Relationships of urinary albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of type 2 (non-insulin-dependent) diabetes mellitus and after 3 months diet therapy","volume":"36","author":"UKPDS Group","year":"1992","journal-title":"Diabetologia"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0120","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/clinchem\/38.11.2294","article-title":"Decreases in albumin\/creatinine and N-acetylglucosaminidase\/creatinine ratios in urine samples stored at -20\u00b0C","volume":"38","author":"Manley","year":"1992","journal-title":"Clin Chem"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0125","first-page":"1021","article-title":"UK Prospective Diabetes Study X. Urinary albumin excretion over 3 years in diet-treated Type 2 (non-insulin-dependent diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia","volume":"36","author":"UKPDS Group","year":"1993","journal-title":"Diabetologia"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0130","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/BF00400195","article-title":"UK Prospective Diabetes Study VIII: Study design, progress and performance","volume":"34","author":"UKPDS Group","year":"1991","journal-title":"Diabetologia"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0135","first-page":"690","article-title":"Chi-Square tests with one degree of freedom; Extensions of the Mantel-Haenszel procedure","volume":"58","author":"Mantel","year":"1961","journal-title":"J Am Stat Assoc"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0140","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0272989X9301300409","article-title":"Markov models in medical decision making: A practical guide","volume":"13","author":"Sonnenberg","year":"1993","journal-title":"Med Decis Making"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0145","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2337\/diabetes.47.11.1786","article-title":"Microalbuminuria and coronary heart disease in NIDDM: An incidence study","volume":"47","author":"Mattock","year":"1998","journal-title":"Diabetes"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0150","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/fampra\/16.1.54","article-title":"Quality of care of patients with diabetes: Collation of data from multi-practice audits of diabetes in primary care","volume":"16","author":"Khunti","year":"1999","journal-title":"Fam Pract"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0155","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2337\/diacare.24.6.979","article-title":"Frequency of blood glucose monitoring in relation to glycemia control in patients with type 2 diabetes","volume":"24","author":"Harris","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0160","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/CS20000335","article-title":"The UKPDS Risk Engine: a model for the risk of coronary heart disease in type 2 diabetes (UKPDS 56)","volume":"101","author":"Stevens","year":"2001","journal-title":"Clin Sci Lond"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0165","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/archopht.1989.01070010250031","article-title":"The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more","volume":"107","author":"Klein","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0170","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/archinte.160.8.1093","article-title":"The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus","volume":"160","author":"Valmadrid","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0175","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1056\/NEJM198402093100605","article-title":"Microalbuminuria predicts clinical preteinuria and early mortality in maturity-onset diabetes","volume":"310","author":"Mogensen","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0180","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00041552-199505000-00004","article-title":"Epidemiology and prevention of diabetic nephropathy","volume":"4","author":"Brancati","year":"1995","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0185","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2337\/diab.43.4.572","article-title":"Incidence of renal failure in NIDDM","volume":"43","author":"Lee","year":"1994","journal-title":"Diabetes"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0190","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000166541","article-title":"Diabetic nephropathy: Natural course, survivorship and therapy","volume":"1","author":"McCrary","year":"1981","journal-title":"Am J Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0195","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1067\/mpd.2000.105141","article-title":"Type 2 diabetes among North American children and adolescents: An epidemiologic review and a public health perspective","volume":"136","author":"Fagot-Campagna","year":"2000","journal-title":"J Pediatr"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0200","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1046\/j.1523-1755.1999.00389.x","article-title":"Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients","volume":"55","author":"Fleischmann","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0205","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJM199311113292012","article-title":"Slowing the progression of diabetic nephropathy","volume":"329","author":"Remuzzi","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0210","doi-asserted-by":"crossref","first-page":"788","DOI":"10.7326\/0003-4819-127-9-199711010-00003","article-title":"Estimated benefits of glycemic control in microvascular complications of type 2 diabetes","volume":"127","author":"Vijan","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0215","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/jarr.2001.21708","article-title":"Diabetes mellitus in Tassin, France: Remarkable transformation in incidence and outcome of ESRD in diabetes","volume":"8","author":"Charra","year":"2001","journal-title":"Adv Ren Replace Ther"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0220","doi-asserted-by":"crossref","first-page":"660","DOI":"10.7326\/0003-4819-131-9-199911020-00005","article-title":"The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors","volume":"131","author":"Golan","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0225","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0149-2918(00)87983-7","article-title":"Economic assessment of troglitazone as an adjunct to sulfonylurea therapy in the treatment of type 2 diabetes","volume":"22","author":"Caro","year":"2000","journal-title":"Clin Ther"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0230","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2337\/diacare.20.5.725","article-title":"Model of complications of NIDDM. I. Model construction and assumptions","volume":"20","author":"Eastman","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0235","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy","volume":"355","author":"Heart Outcome Prevention Evaluation Study Investigators","year":"2000","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0240","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0245","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archinte.1997.00440340025002","article-title":"The association between microalbuminuria and mortality in non-insulin dependent diabetes mellitus: A systematic overview of the literature","volume":"157","author":"Dinneen","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0250","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(00)02456-9","article-title":"Premature cardiovascular disease in chronic renal failure","volume":"356","author":"Baigent","year":"2000","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0255","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0260","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/bmj.316.7134.823","article-title":"Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)","volume":"316","author":"Turner","year":"1998","journal-title":"BMJ"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0265","series-title":"Coronary Heart Disease Statistics 2002","author":"Petersen","year":"2002"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0270","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","article-title":"Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial","volume":"134","author":"Mann","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0275","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0280","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of Losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0285","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(95)91747-0","article-title":"Prevention of diabetic renal disease with special reference to microalbuminuria","volume":"346","author":"Mogensen","year":"1995","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1046\/j.1523-1755.2003.00712.x_bb0290","first-page":"S69","article-title":"Position Statement Diabetic Nephropathy","volume":"24","author":"American Diabetes Association","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1046\/j.1523-1755.2003.00712.x_bb0295","series-title":"Primer on Kidney Diseases","first-page":"215","article-title":"Diabetic nephropathy","author":"Breyer","year":"1998"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815488635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815488635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T02:25:26Z","timestamp":1655605526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815488635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S0085253815488635"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00712.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}